149 related articles for article (PubMed ID: 19005676)
1. Sphingosine-1-phosphate receptor 1 is a useful adjunct for distinguishing vascular neoplasms from morphological mimics.
Akiyama T; Hamazaki S; Monobe Y; Nishimura H; Irei I; Sadahira Y
Virchows Arch; 2009 Feb; 454(2):217-22. PubMed ID: 19005676
[TBL] [Abstract][Full Text] [Related]
2. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Miettinen M; Wang ZF
Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
[TBL] [Abstract][Full Text] [Related]
3. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
Folpe AL; Chand EM; Goldblum JR; Weiss SW
Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
[TBL] [Abstract][Full Text] [Related]
4. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
5. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
6. Thrombomodulin as a marker of vascular and lymphatic tumours.
Appleton MA; Attanoos RL; Jasani B
Histopathology; 1996 Aug; 29(2):153-7. PubMed ID: 8872149
[TBL] [Abstract][Full Text] [Related]
7. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
Sirgi KE; Wick MR; Swanson PE
Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of WT-1 cytoplasmic stain in variety of vascular lesions.
Galfione SK; Ro JY; Ayala AG; Ge Y
Int J Clin Exp Pathol; 2014; 7(5):2536-43. PubMed ID: 24966966
[TBL] [Abstract][Full Text] [Related]
11. Primary Vascular Tumors of Bone: A Monoinstitutional Morphologic and Molecular Analysis of 427 Cases With Emphasis on Epithelioid Variants.
Righi A; Sbaraglia M; Gambarotti M; Gibertoni D; Rovira MP; Benini S; Errani C; Brenca M; Maestro R; Dei Tos AP
Am J Surg Pathol; 2020 Sep; 44(9):1192-1203. PubMed ID: 32271190
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of sphingosine-1-phosphate receptor 1 in vascular and lymphatic endothelial cells.
Akiyama T; Sadahira Y; Matsubara K; Mori M; Igarashi Y
J Mol Histol; 2008 Oct; 39(5):527-33. PubMed ID: 18758970
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
14. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations.
Suster S; Wong TY
Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723
[TBL] [Abstract][Full Text] [Related]
15. Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Analysis of 39 cases and delineation of two new entities.
Chan JK; Frizzera G; Fletcher CD; Rosai J
Am J Surg Pathol; 1992 Apr; 16(4):335-50. PubMed ID: 1373579
[TBL] [Abstract][Full Text] [Related]
16. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA
Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549
[TBL] [Abstract][Full Text] [Related]
17. Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas.
Miettinen M; Sarlomo-Rikala M; Wang ZF
Am J Surg Pathol; 2011 Dec; 35(12):1848-56. PubMed ID: 21959309
[TBL] [Abstract][Full Text] [Related]
18. ERG expression in epithelioid sarcoma: a diagnostic pitfall.
Miettinen M; Wang Z; Sarlomo-Rikala M; Abdullaev Z; Pack SD; Fetsch JF
Am J Surg Pathol; 2013 Oct; 37(10):1580-5. PubMed ID: 23774169
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors.
Miettinen M; Rikala MS; Rys J; Lasota J; Wang ZF
Am J Surg Pathol; 2012 Apr; 36(4):629-39. PubMed ID: 22314185
[TBL] [Abstract][Full Text] [Related]
20. Occasional staining for p63 in malignant vascular tumors: a potential diagnostic pitfall.
Kallen ME; Nunes Rosado FG; Gonzalez AL; Sanders ME; Cates JM
Pathol Oncol Res; 2012 Jan; 18(1):97-100. PubMed ID: 21667345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
